These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 513944)

  • 1. Binding of 3H-lisuride hydrogen maleate to striatal membranes of rat brain.
    Fujita N; Saito K; Yonehara N; Watanabe Y; Yoshida H
    Life Sci; 1979 Sep; 25(11):969-73. PubMed ID: 513944
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of GTP and sodium on rat striatal dopamine receptors labeled with lisuride.
    Uzumaki H; Govoni S; Memo M; Carruba MO; Trabucchi M; Spano PF
    Brain Res; 1982 Sep; 248(1):185-7. PubMed ID: 7127137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct binding of 3H-lisuride to adrenergic and serotonergic receptors.
    Battaglia G; Titeler M
    Life Sci; 1981 Aug; 29(9):909-16. PubMed ID: 7300582
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of (3H)-terguride and (3H)-spiperone binding to dopamine receptors in the rat striatum.
    Valchár M; Dobrovský K; Krejcí I; Dlabac A
    Act Nerv Super (Praha); 1989 Apr; 31(1):77-9. PubMed ID: 2675526
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding characteristics of the dopamine agonist/antagonist [3H]terguride (transdihydrolisuride) in the rat striatum.
    Valchár M; Vrsecká M; Krejcí I; Dlabac A
    Eur J Pharmacol; 1987 Apr; 136(1):97-101. PubMed ID: 3297739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of apomorphine enantiomers and of lisuride on 3,4-dihydroxyphenylalanine production in striatal synaptosomes.
    Bräutigam M; Kittner B; Laschinski G
    Mol Pharmacol; 1985 Dec; 28(6):515-20. PubMed ID: 3935908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of antiparkinsonian ergot derivatives to the dopamine receptor.
    Weir RL; Hruska RE; Silbergeld EK
    Psychopharmacology (Berl); 1981; 75(2):119-23. PubMed ID: 6798600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic and acute treatment of antipsychotic drugs on calmodulin release from rat striatal membranes.
    Gnegy ME; Lau YS
    Neuropharmacology; 1980 Mar; 19(3):319-23. PubMed ID: 6158710
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice.
    Horowski R; Wachtel H
    Eur J Pharmacol; 1976 Apr; 36(2):373-83. PubMed ID: 945166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
    Friend WC; Brown GM; Jawahir G; Lee T; Seeman P
    Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lisuride inhibits 3H-spiroperidol binding to membranes isolated from striatum.
    Fujita N; Saito K; Yonehara N; Yoshida H
    Neuropharmacology; 1978 Dec; 17(12):1089-91. PubMed ID: 745698
    [No Abstract]   [Full Text] [Related]  

  • 12. [76Br]bromolisuride: a new tool for quantitative in vivo imaging of D-2 dopamine receptors.
    Maziere B; Loc'h C; Stulzaft O; Hantraye P; Ottaviani M; Comar D; Maziere M
    Eur J Pharmacol; 1986 Aug; 127(3):239-47. PubMed ID: 2944753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of [3H]pergolide mesylate to dopamine receptors of mammalian brains.
    Wong DT; Bymaster FP; Lane PT; Kau D; Bach NJ; Kornfeld EC
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):195-210. PubMed ID: 7444158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple postsynaptic dopamine receptors and behavioral manifestation.
    Fujita N; Hirata A; Saito K; Yoshida H
    Pharmacol Biochem Behav; 1982 Mar; 16(3):437-40. PubMed ID: 6177010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors.
    Lew JY; Hata F; Ohashi T; Goldstein M
    J Neural Transm; 1977; 41(2-3):109-21. PubMed ID: 21229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of haloperidol and apomorphine on the K+-depolarized overflow of [3H] dopamine from rat striatal slices.
    Miller JC; Friedhoff AJ
    Biochem Pharmacol; 1979 Mar; 28(5):688-90. PubMed ID: 444255
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoamine oxidase inhibitors inhibit [3H]quinpirole binding in rat striatal membranes.
    Levant B; Grigoriadis DE; DeSouza EB
    Eur J Pharmacol; 1993 Jul; 246(2):171-8. PubMed ID: 8104153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H
    Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]spiperone binding in the nigrostriatal system in human brain.
    Ruberg M; Bokobza B; Javoy-Agid F; Montfort JC; Agid Y
    Eur J Pharmacol; 1984 Mar; 99(2-3):159-65. PubMed ID: 6203765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment.
    MacKenzie RG; Zigmond MJ
    J Neurochem; 1984 Nov; 43(5):1310-8. PubMed ID: 6208330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.